Many thanks to the following companies for providing grants in support of the medical education portion of the 2023 APA Scientific Conference:
The APA Foundation was created in 2008 to raise funds for education and research in the field of mental health. Your donations will help the APA Foundation bring noted speakers to present at future APA Conferences while still keeping registration fees low so as to encourage full industry participation and education
Eisai is a R&D company that seeks innovative solutions in disease prevention, treatment, and care in Neurology and Oncolgy. Dayvigo is the first Orexin receptor antagonist indicated for the treatment of Insomnia in Canada with over 3.5 million patients worldwide.
Viatris is the sole provider of clozapine originator brand in all countries outside of North America – allowing us to share the best clozapine practices worldwide. In Canada, Viatris markets Gen-Clozapine and has provided exceptional patient care through our Gen-Clozapine Access Network (GenCAN) for over 18 years.